The global gastrointestinal endoscopy market continues to witness steady growth as healthcare providers increasingly adopt minimally invasive diagnostic and therapeutic procedures for gastrointestinal diseases. According to recent market analysis, the global gastrointestinal endoscopy market was valued at USD 17.07 billion in 2025 and is projected to grow from USD 18.14 billion in 2026 to USD 29.44 billion by 2034, registering a compound annual growth rate (CAGR) of 6.24% during the forecast period from 2026 to 2034.

Market Overview

Gastrointestinal endoscopy plays a critical role in the diagnosis, monitoring, and treatment of disorders affecting the digestive tract. The technology enables physicians to visualize the upper and lower gastrointestinal tract using specialized instruments equipped with cameras and lighting systems. Over the years, gastrointestinal endoscopy has evolved from rigid visualization devices into advanced digital platforms capable of supporting highly accurate diagnostic and therapeutic interventions.

Continuous technological improvements have transformed the field, including the introduction of video endoscopy systems, capsule endoscopy, artificial intelligence-assisted diagnostics, and robotic-assisted procedures. These innovations have improved procedural accuracy, patient comfort, and clinical outcomes while expanding the scope of gastrointestinal disease management.

Growth Drivers

The increasing prevalence of chronic gastrointestinal diseases remains one of the primary factors driving market growth. Conditions such as colorectal cancer, gastric cancer, inflammatory bowel disease, gastrointestinal bleeding, and obesity-related digestive disorders continue to create significant demand for advanced diagnostic solutions.

The growing burden of gastrointestinal cancers is particularly influencing the adoption of endoscopic procedures. Early diagnosis through endoscopy enables healthcare professionals to identify precancerous lesions and cancerous growths at earlier stages, improving treatment outcomes and survival rates. As awareness regarding preventive healthcare and early screening programs increases, demand for gastrointestinal endoscopy procedures is expected to rise further.

Another major growth driver is the increasing preference for minimally invasive surgical and diagnostic procedures. Compared with traditional open surgeries, endoscopic procedures typically involve reduced patient discomfort, shorter hospital stays, lower infection risks, and faster recovery times. These benefits are encouraging both healthcare providers and patients to choose endoscopic interventions whenever clinically appropriate.

Emerging Market Trends

Technological innovation continues to reshape the gastrointestinal endoscopy landscape. Artificial intelligence is becoming increasingly integrated into endoscopic systems, enabling enhanced detection of abnormalities such as colorectal polyps, early-stage cancers, and tissue abnormalities. AI-powered diagnostic support systems assist clinicians in identifying lesions that may otherwise be overlooked, contributing to improved diagnostic accuracy.

Robotic-assisted endoscopy is also emerging as an important trend within the market. Advanced robotic platforms are being developed to improve maneuverability, visualization, and procedural precision while minimizing patient discomfort. In addition, the growing adoption of single-use and disposable endoscopes is addressing concerns related to infection control and device reprocessing, particularly in hospitals and outpatient care facilities.

Capsule endoscopy continues to gain popularity due to its non-invasive nature and ability to provide detailed imaging of the gastrointestinal tract without requiring surgical incisions. As these technologies become more accessible, they are expected to contribute significantly to future market growth.

Market Challenges

Despite favorable growth prospects, the gastrointestinal endoscopy market faces several operational challenges. One of the most significant barriers is the shortage of skilled healthcare professionals trained in endoscopic procedures and device reprocessing.

Successful endoscopy programs require experienced physicians, technicians, and support staff capable of performing procedures safely and effectively. In many developing and emerging economies, limited access to specialized training programs and insufficient clinical exposure create workforce shortages that may restrict procedure volumes.

The complexity of advanced endoscopic procedures also contributes to longer learning curves for healthcare professionals. In addition, healthcare facilities must invest in staff training and equipment maintenance to ensure patient safety and compliance with quality standards.

Opportunities Across the Industry

Advancements in artificial intelligence, machine learning, and robotics present substantial opportunities for market participants. AI-enabled diagnostic tools are increasingly being incorporated into routine gastrointestinal screening procedures to enhance lesion detection and improve clinical decision-making.

The development of next-generation robotic endoscopy systems offers opportunities to improve procedural efficiency and expand therapeutic capabilities. Meanwhile, growing investments in research and development are supporting the introduction of innovative products designed to improve visualization, navigation, and patient outcomes.

Expanding healthcare infrastructure in emerging economies, coupled with increasing awareness of gastrointestinal disease screening, is expected to create additional opportunities for manufacturers and healthcare providers over the coming years.

Regional Insights

North America accounted for the largest share of the global gastrointestinal endoscopy market and is expected to maintain its leading position throughout the forecast period. The region benefits from advanced healthcare infrastructure, strong adoption of innovative medical technologies, high awareness regarding preventive screening, and widespread availability of minimally invasive procedures. The United States remains a major contributor to regional growth due to significant investments in healthcare technology and the presence of leading industry participants.

Europe is projected to be the fastest-growing regional market during the forecast period, expanding at a CAGR of 6.40%. Growth is supported by increasing demand for minimally invasive procedures, favorable healthcare systems, and strong innovation activity among regional medical device manufacturers. Countries such as Germany, Italy, and Spain continue to witness growing utilization of gastrointestinal endoscopy, particularly among aging populations.

The Asia-Pacific region is also experiencing robust growth due to rising incidences of gastrointestinal diseases, expanding healthcare infrastructure, and increasing healthcare expenditures. Countries including China, Japan, India, South Korea, and Australia are investing heavily in advanced diagnostic technologies, creating favorable conditions for market expansion.

Meanwhile, Latin America and the Middle East & Africa are emerging markets where improving healthcare access, medical tourism, and growing awareness of gastrointestinal disorders are contributing to increased adoption of endoscopic procedures.

Segment Analysis

Based on type, the market is segmented into gastrointestinal endoscopes and endoscopic systems and gastrointestinal endotherapy. The gastrointestinal endotherapy segment currently holds the largest market share and is anticipated to maintain its dominance throughout the forecast period. The segment includes devices such as ultrasound endoscopes, gastrointestinal stents, biopsy devices, hemostasis devices, retrieval devices, balloon dilators, and ERCP devices that are widely used in therapeutic gastrointestinal interventions.

The gastrointestinal endoscopes and endoscopic systems segment continues to evolve through the adoption of advanced video scopes, high-definition visualization systems, and capsule endoscopy technologies. These innovations are enhancing diagnostic capabilities while improving patient experience.

By end user, the market is categorized into hospitals, ambulatory surgery centers, and others. Hospitals remain the leading end-user segment due to their ability to support complex endoscopic procedures and invest in advanced medical equipment. However, ambulatory surgery centers are gaining traction as healthcare systems increasingly shift suitable procedures toward cost-effective outpatient settings.

Competitive Landscape

The global gastrointestinal endoscopy market is characterized by ongoing technological innovation and strong competition among established medical device manufacturers. Key industry participants continue to focus on product development, strategic collaborations, and geographic expansion to strengthen their market positions.

Major companies operating in the market include Medtronic plc, SonoScape, Teleflex Inc., KARL STORZ SE & Co. KG, Ambu A/S, Conmed Corporation, HOYA Corporation, Olympus Corporation, Fujifilm Corporation, Boston Scientific Corporation, Cook Group Inc., EndoMed Systems GmbH, CapsoVision, Inc., HuiZhou Xzing Technology Co., Ltd., Endogene Ltd., and Envaste Limited.

As innovation accelerates across AI-assisted diagnostics, robotic technologies, and disposable endoscopy solutions, competition is expected to intensify throughout the forecast period.

Click to Read the Complete Insights & Report: https://straitsresearch.com/report/gastrointestinal-endoscopy-market

About Straits Research

Straits Research is a leading market research and intelligence organization providing comprehensive industry insights, analytics, and advisory services across diverse sectors. The company delivers in-depth market assessments, competitive intelligence, and strategic research reports that help organizations identify growth opportunities, evaluate market dynamics, and make informed business decisions. Through a combination of rigorous research methodologies and data-driven analysis, Straits Research supports businesses, investors, and stakeholders across global markets.